OSOyindamola John Samson

Oyindamola John Samson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oyindamola John Samson has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biofilm Formation in the Food Industry Under Changing Climatic Conditions

    by Bukola Margaret Popoola, Oyindamola John Samson, Tosin Olateru

    Given the profound implications of biofilm formation in the food industry, including its role as a major driver of food spoilage, foodborne disease outbreaks, and the deterioration of processing equipment, a comprehensive understanding of the factors governing bacterial growth and biofilm development is indispensable. These factors, however, cannot be considered in isolation. Emerging evidence suggests that climate change, through rising global temperatures, altered humidity, fluctuating water availability, and shifts in nutrient dynamics, may further modulate microbial behaviour, enhancing the propensity of biofilm formation by pathogens and spoilage organisms. Understanding that biofilms can influence and are influenced by climate change is crucial to their effective management in the food industry. Climate-driven shifts in biofilm behaviour may complicate existing safety and hygiene protocols, necessitating more stringent control measures such as climate-adaptive sanitation technologies, infrastructure redesign, and updated monitoring frameworks capable of responding to the rapidly changing microbiological landscape of food-processing environments. Therefore, as the environment becomes more variable and extreme, it is critical to investigate biofilm dynamics to protect public health, manage ecosystems, and ensure sustainable industrial practices. This review aims to describe how climate-driven environmental pressures make biofilm eradication in the food industry particularly challenging, and to address innovative strategies for biofilm management and future research directions towards effective management.

  • Antibiotic Abuse Surveillance: Future Prospects

    by Oyindamola John Samson, Stephen Olaosebikan Makanjuola, Abosede Olubunmi Obadina, Ayush Madan, Moses Sunday Afariogun, Ismail Babatunde Onajobi

  • Digital Healing for Diabetic Disabilities: Tools for Monitoring, Mobility, and Self-Management

    by Krishnendu Adhikary, Krishnendu Ganguly, Monalisha Maity, Priyanka Mahata, Oyindamola John Samson


  • Open Access

    Viruses that heal: harnessing bacteriophages in the era of antibiotic resistance

    by Theresa A. Awotundun, Oyindamola J. Samson, Afolake A. Olanbiwoninu, Авотундун Тереза Абимбола, Сэмсон Ойиндамола Джон

    The global rise in antimicrobial resistance (AMR) poses an urgent threat to public health, and novel alternatives to traditional antibiotics are needed. One of the most promising options is bacteriophages, viruses that infect and destroy bacteria. Once overshadowed by the discovery of antibiotics, phage therapy is now regaining attention, driven by advances in genomics, synthetic biology, and targeted medicine. This review examines the biology, diversity, and therapeutic use of bacteriophages in treating bacterial infections, especially those caused by multidrug-resistant pathogens. It also discusses how phages act through natural mechanisms, such as lytic enzymes (holins, endolysins, and muralysins), and highlights new genetic engineering techniques, such as CRISPR-Cas systems, phage recombineering, and synthetic genome reboots. In addition to clinical applications, we evaluate phages as biocontrol agents for food safety, environmental sanitation, and biofilm management. Additionally, the article explores key issues in phage therapy, including regulatory frameworks, formulation stability, dynamics of phage-host resistance, and the importance of rapid diagnosis. When properly integrated into modern health and biotechnology practices, bacteriophages offer significant potential and a sustainable solution to the global challenge of antimicrobial resistance.

  • Targeting ecDNA

    by Oyindamola John Samson, John Olusola Olayiwola, Ayush Madan, Titilola Fausat Salisu, Ismail Babatunde Onajobi

    Extrachromosomal DNA (ecDNA) has emerged as a crucial player in cancer biology, particularly in driving oncogene amplification, promoting intratumoral heterogeneity, and conferring resistance to conventional therapies. Unlike chromosomal DNA, ecDNA exists outside the linear genome and replicates independently, enabling rapid evolution of cancer cells and enhanced expression of oncogenes without the constraints of chromatin regulation. Recent advances in sequencing and imaging technologies have deepened our understanding of ecDNA’s structural complexity, biogenesis, and functional roles in tumor progression. These insights have highlighted ecDNA as a promising therapeutic target. Novel strategies aiming to target ecDNA include disrupting its formation, inhibiting its replication, promoting its degradation, or re-sensitizing ecDNA-harboring cells to existing therapies. CRISPR-Cas systems, DNA-damaging agents, and inhibitors of DNA repair pathways have shown potential in selectively impairing ecDNA-driven oncogenic processes. Additionally, targeting the unique vulnerabilities of ecDNA-positive tumors, such as their dependence on specific transcriptional programs and stress response pathways, offers new avenues for precision medicine. This review explores the biology of ecDNA, its implications in cancer, and current progress in therapeutic strategies targeting ecDNA. Harnessing these novel approaches may pave the way for more effective and durable cancer treatments, especially in refractory and aggressive tumor types.

  • Open Access

    Microarray Survival Analysis of Five Cancer Gene Sequences and its Application using Bayesian Additive Regression Trees (BART)

    by F. A. Okolie, B. O. Fagbemigun, O. J. Samson

    An important tool in the Genomic approach is the widely used Microarray interventions to effectively and accurately predict survival time and risk analysis of patients. This study is aimed to present and examine the risk impact of five cancer gene sequences with different high-dimensional microarray data sets, through survival analysis. GSE10300; GSE14333; GSE16446; GSE17618 and GSE20685 data sets with 16,183; 54,712; 54,739; 54,726 and 54,739 gene counts from sample sizes 44, 226, 107, 44 and 327 respectively were selected from the NCBI database to identify their risk impact. Then the classical Cox Proportional Hazard (CoxPH), Bayesian Adaptive Spline Surface (BASS) and Bayesian Additive Regression Tree (BART) models were employed to analyze each of the five data sets. Each model’s prediction performance was measured using the Root Mean Squared Error (RSME). The fol-lowing, R packages ‘survive’ for CoxPH; ‘BASS’ for BASS and ‘bartMachine’ for BART were utilized in obtaining the results. Finally, influential variable plots were shown to indicate the most important main effects and interactions for the five microarray datasets. Varying median hazard values and traces of yellow boxes across the diagonals of the heatmap diagrams indicate multi-collinearity between genes, implying misleading results by the CoxPH model, while leveraging superiority of BART model over the BASS and CoxPH models. The RSME plots successfully identify some influential genes among thou-sands of genes across the five real-life microarray datasets analyzed: CoxPH model shows a moderate level of predictive accuracy while the BASS model exhibits both strengths and weaknesses depending on the number of predictors used, significantly higher than CoxPH. The BART model, on the other hand, with the lowest RSME, consistently demonstrates its superior, stable and consistent predictive performance over CoxPH and BASS models. This study gives a more distinct and nuanced understanding of genes interactions and influence, as well as provide improved prognostic tools and personalized treatment strategies for cancer patients’ risks and survival.

  • Open Access

    Seroprevalence of Anti-Mpox Virus IgG Antibody and Awareness of Mpox Disease in Ibadan, Southwest Nigeria

    by John Olusola Olayiwola, Adesuwa Oluwatofunmi Akagbosu, Oyindamola John Samson, Ademola Emmanuel Alaba, Babalola Sunday Aponjolosun, Stephen Ademola Soyemi

    Purpose. Mpox cases were previously common in children; recent outbreaks of clade II have mostly affected young adults. Therefore, this study examines the knowledge, attitudes, and seroprevalence of the Mpox virus among consenting participants in Ibadan. Materials and methods. Eligible individuals were those who voluntarily participated in the study and met the inclusion criteria specified for the study. A cross-sectional survey was conducted involving 94 respondents, investigating socio-demographic factors, awareness levels, attitudes toward prevention, and infection rates. The anti-Mpox virus IgG antibody was detected quantitatively using the Enzyme-Linked Immunosorbent Assay (ELISA) technique. The data were then analyzed using the χ2 test, while the antibody quantification was displayed with a Box and Whisker plot; statistical significance was determined at p 0.05. Results. The majority of respondents were female (66.7%) and aged 58 years and above (20.0%). Most had tertiary (40.0%) and secondary education (34.4%). Awareness of the Mpox was moderate, with 61.1% having heard of the virus, primarily through news (20.0%) and healthcare workers (18.9%). However, knowledge gaps were evident: only 38.9% recognized symptoms, and 40.0% understood modes of transmission. Attitudes towards prevention were generally positive; 60.0% believed Mpox could be prevented, and 73.3% were willing to take a vaccine. Still, readiness to engage in screening was low; 81.1% had never been tested, and 58.9% were unaware of local test availability. Regarding seroprevalence, females showed a significantly higher infection rate (27.4%) than males (9.6%) (χ2 = 3.854, p = 0.050). Age-wise, the highest infection rates occurred in those 18 years (61.5%) and 53–57 years (66.6%) (χ2 = 30.817, p = 0.000), indicating significant age-related differences. Conclusion. The findings highlight the need for targeted public health education, increased test access, and focused intervention strategies to improve Mpox virus prevention and control, especially among vulnerable age groups and under-informed populations.


  • Biomanufacturing Challenges in Developing Economies

    by Oyindamola John Samson, Jamiu Oluwatosin Adeyemi, Kashish Saxena, Ismail Babatunde Onajobi

    Biomanufacturing, the application of biological systems for producing bio-based products, holds significant potential for industrial growth, economic development, and sustainability. However, developing economies face multiple challenges that hinder its progress. Key constraints include limited access to advanced bioprocessing technologies, inadequate infrastructure, and insufficient research funding. Additionally, regulatory bottlenecks, weak policy frameworks, and a lack of skilled workforce further impede the sector's expansion. The high cost of raw materials and dependence on imported biotechnological inputs exacerbate financial burdens on local industries. Moreover, inconsistent power supply and poor waste management practices present operational inefficiencies. Addressing these challenges requires comprehensive policy reforms, capacity-building initiatives, and strategic investments to enhance the competitiveness of biomanufacturing industries in developing economies.

  • Open Access

    Molecular quantification of gbpA1 gene expression in Vibrio cholerae exposed to Hunteria umbellata methanol leaf extract

    by Titilola F. Salisu, Muinah A. Fowora, Tajudeen O. Yahaya, Tawakalt A. Fagbayi, Oyindamola J. Samson, Halima Audu-Ohida

    Leaves are the most common parts of Hunteria umbellata used to treat cholera infections in traditional medicine. However, inappropriate doses are often abused. Despite continuous colonization of small intestine epithelium by Vibrio cholerae (VC), there is a paucity of literature in in vitro molecular toxicology of graded doses of H. umbellata leaf extract. Particularly, targeting the effect on gene expression of N-acetyl glucosamine-binding protein A (GbpA), which is critical to thwart indiscriminate consumption during cholera treatment. This study evaluated in vitro molecular toxicological activities of V. cholerae exposed to eight varying concentrations (500 to 3.90625 μgμL-1) of methanol H. umbellata leaf extract. The broth microdilution method was employed for bacterial assay, and two-step reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was harnessed to quantify expression of the GbpA I gene. The hybrid gas chromatograph–mass spectrometer (GC–MS) technique was used to identify chemical components in H. umbellata. Results disclosed significant (p < 0.05) dose-response mode toxicity in the bactericidal property of all tested concentrations of H. umbellata leaf extract compared to controls. Quantified expression of GbpA I in V. cholerae was most significantly elevated (p < 0.05) at 500 μgμL-1 and least at 125 μgμL-1 of H. umbellata extract when compared with control. Eight phytochemicals and ten analytical grade compounds were identified, predominantly constituting fatty acids. Conspicuously, the research highlighted the potential menace of amplified V. cholerae infection at higher doses of H. umbellata leaf extract, ascribed to the expression of the virulence factor GbpA I gene, that initiates colonization of intestines and persistent reinfection of cholera. Thus, the general populace should be alerted of dangers involved in excessive drinking of infused H. umbellata leaf to treat diarrhea, as it could lead to augmented expression of the gene responsible for more severe cholera disease.

  • Open Access

    Serologic evidence of Zika virus, hepatitis B virus and rubella virus in pregnant women attending a south-west based Nigerian tertiary care centre An enzyme-linked immunosorbent assay based study

    by H. A. Adekola, D. I. Fallatah, O. A. Oyesanya, A. T. Amusan, I. B. Onajobi, O. J. Samson, O. D. Popoola, H. O. Egberongbe

    This study investigated serological evidence for Zika, hepatitis B and rubella virus infection in 92 pregnant women attending a south-west based Nigerian tertiary care centre from January to May 2023. Of the 92 samples, 31 (33.7%), 14 (15.2%), and 90 (97.8%) exhibited seropositivity for Zika, hepatitis B, and rubella virus respectively. Cases of co-positives were also reported, with 28.3% seropositive for both Zika and rubella virus, 10.9% for hepatitis B and rubella virus, and 4.3% for all three viruses. The findings of this study underscore that a considerable portion of participants are susceptible to Zika and hepatitis B virus. Conversely, the majority of the participants appeared to be protected against rubella virus. This study strongly advocates initiation of public awareness campaigns and formulation of vaccination policies targeting women of reproductive age. Such measures are crucial for countering viral infections which could harm the developing foetus and give rise to pregnancy-related complications.